<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2018-01-31" version="164">
<accession>Q9Y4K0</accession>
<accession>B2R5Q0</accession>
<accession>Q53HV3</accession>
<accession>Q9BW70</accession>
<accession>Q9Y5Y8</accession>
<name>LOXL2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Lysyl oxidase homolog 2</fullName>
<ecNumber evidence="8 9 16">1.4.3.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Lysyl oxidase-like protein 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Lysyl oxidase-related protein 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Lysyl oxidase-related protein WS9-14</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">LOXL2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="8157" last="8160">
<title>Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence.</title>
<authorList>
<person name="Saito H."/>
<person name="Papaconstantinou J."/>
<person name="Sato H."/>
<person name="Goldstein S."/>
</authorList>
<dbReference type="PubMed" id="9079631"/>
<dbReference type="DOI" id="10.1074/jbc.272.13.8157"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT LEU-570</scope>
<source>
<tissue>Adipose tissue</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT LEU-570</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="12939" last="12944">
<title>The LOXL2 gene encodes a new lysyl oxidase-like protein and is expressed at high levels in reproductive tissues.</title>
<authorList>
<person name="Jourdan-Le Saux C."/>
<person name="Tronecker H."/>
<person name="Bogic L."/>
<person name="Bryant-Greenwood G.D."/>
<person name="Boyd C.D."/>
<person name="Csiszar K."/>
</authorList>
<dbReference type="PubMed" id="10212285"/>
<dbReference type="DOI" id="10.1074/jbc.274.18.12939"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 202-774</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="3446" last="3458">
<title>A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.</title>
<authorList>
<person name="Peinado H."/>
<person name="Del Carmen Iglesias-de la Cruz M."/>
<person name="Olmeda D."/>
<person name="Csiszar K."/>
<person name="Fong K.S."/>
<person name="Vega S."/>
<person name="Nieto M.A."/>
<person name="Cano A."/>
<person name="Portillo F."/>
</authorList>
<dbReference type="PubMed" id="16096638"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600781"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SNAI1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="6658" last="6669">
<title>The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.</title>
<authorList>
<person name="Schietke R."/>
<person name="Warnecke C."/>
<person name="Wacker I."/>
<person name="Schodel J."/>
<person name="Mole D.R."/>
<person name="Campean V."/>
<person name="Amann K."/>
<person name="Goppelt-Struebe M."/>
<person name="Behrens J."/>
<person name="Eckardt K.U."/>
<person name="Wiesener M.S."/>
</authorList>
<dbReference type="PubMed" id="20026874"/>
<dbReference type="DOI" id="10.1074/jbc.M109.042424"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="20964" last="20974">
<title>Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor.</title>
<authorList>
<person name="Rodriguez H.M."/>
<person name="Vaysberg M."/>
<person name="Mikels A."/>
<person name="McCauley S."/>
<person name="Velayo A.C."/>
<person name="Garcia C."/>
<person name="Smith V."/>
</authorList>
<dbReference type="PubMed" id="20439985"/>
<dbReference type="DOI" id="10.1074/jbc.M109.094136"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Nat. Med." volume="16" first="1009" last="1017">
<title>Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.</title>
<authorList>
<person name="Barry-Hamilton V."/>
<person name="Spangler R."/>
<person name="Marshall D."/>
<person name="McCauley S."/>
<person name="Rodriguez H.M."/>
<person name="Oyasu M."/>
<person name="Mikels A."/>
<person name="Vaysberg M."/>
<person name="Ghermazien H."/>
<person name="Wai C."/>
<person name="Garcia C.A."/>
<person name="Velayo A.C."/>
<person name="Jorgensen B."/>
<person name="Biermann D."/>
<person name="Tsai D."/>
<person name="Green J."/>
<person name="Zaffryar-Eilot S."/>
<person name="Holzer A."/>
<person name="Ogg S."/>
<person name="Thai D."/>
<person name="Neufeld G."/>
<person name="Van Vlasselaer P."/>
<person name="Smith V."/>
</authorList>
<dbReference type="PubMed" id="20818376"/>
<dbReference type="DOI" id="10.1038/nm.2208"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Blood" volume="118" first="3979" last="3989">
<title>Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane.</title>
<authorList>
<person name="Bignon M."/>
<person name="Pichol-Thievend C."/>
<person name="Hardouin J."/>
<person name="Malbouyres M."/>
<person name="Brechot N."/>
<person name="Nasciutti L."/>
<person name="Barret A."/>
<person name="Teillon J."/>
<person name="Guillon E."/>
<person name="Etienne E."/>
<person name="Caron M."/>
<person name="Joubert-Caron R."/>
<person name="Monnot C."/>
<person name="Ruggiero F."/>
<person name="Muller L."/>
<person name="Germain S."/>
</authorList>
<dbReference type="PubMed" id="21835952"/>
<dbReference type="DOI" id="10.1182/blood-2010-10-313296"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="1561" last="1572">
<title>LOXL2-mediated matrix remodeling in metastasis and mammary gland involution.</title>
<authorList>
<person name="Barker H.E."/>
<person name="Chang J."/>
<person name="Cox T.R."/>
<person name="Lang G."/>
<person name="Bird D."/>
<person name="Nicolau M."/>
<person name="Evans H.R."/>
<person name="Gartland A."/>
<person name="Erler J.T."/>
</authorList>
<dbReference type="PubMed" id="21233336"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-2868"/>
</citation>
<scope>ROLE IN TUMOR PROGRESSION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="EMBO Mol. Med." volume="3" first="528" last="544">
<title>Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas.</title>
<authorList>
<person name="Moreno-Bueno G."/>
<person name="Salvador F."/>
<person name="Martin A."/>
<person name="Floristan A."/>
<person name="Cuevas E.P."/>
<person name="Santos V."/>
<person name="Montes A."/>
<person name="Morales S."/>
<person name="Castilla M.A."/>
<person name="Rojo-Sebastian A."/>
<person name="Martinez A."/>
<person name="Hardisson D."/>
<person name="Csiszar K."/>
<person name="Portillo F."/>
<person name="Peinado H."/>
<person name="Palacios J."/>
<person name="Cano A."/>
</authorList>
<dbReference type="PubMed" id="21732535"/>
<dbReference type="DOI" id="10.1002/emmm.201100156"/>
</citation>
<scope>ROLE IN TUMOR PROGRESSION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="Mol. Biol. Rep." volume="38" first="145" last="149">
<title>The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin.</title>
<authorList>
<person name="Kim Y.M."/>
<person name="Kim E.C."/>
<person name="Kim Y."/>
</authorList>
<dbReference type="PubMed" id="20306300"/>
<dbReference type="DOI" id="10.1007/s11033-010-0088-0"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="3541" last="3549">
<title>The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation.</title>
<authorList>
<person name="Lugassy J."/>
<person name="Zaffryar-Eilot S."/>
<person name="Soueid S."/>
<person name="Mordoviz A."/>
<person name="Smith V."/>
<person name="Kessler O."/>
<person name="Neufeld G."/>
</authorList>
<dbReference type="PubMed" id="22157764"/>
<dbReference type="DOI" id="10.1074/jbc.M111.261016"/>
</citation>
<scope>MUTAGENESIS OF TYR-689</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="Mol. Cell" volume="46" first="369" last="376">
<title>Lysyl oxidase-like 2 deaminates lysine 4 in histone H3.</title>
<authorList>
<person name="Herranz N."/>
<person name="Dave N."/>
<person name="Millanes-Romero A."/>
<person name="Morey L."/>
<person name="Diaz V.M."/>
<person name="Lorenz-Fonfria V."/>
<person name="Gutierrez-Gallego R."/>
<person name="Jeronimo C."/>
<person name="Di Croce L."/>
<person name="Garcia de Herreros A."/>
<person name="Peiro S."/>
</authorList>
<dbReference type="PubMed" id="22483618"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.03.002"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 626-HIS--HIS-628</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="5357" last="5363">
<title>Post-translational Modifications of Recombinant Human Lysyl Oxidase-like 2 (rhLOXL2) Secreted from Drosophila S2 Cells.</title>
<authorList>
<person name="Xu L."/>
<person name="Go E.P."/>
<person name="Finney J."/>
<person name="Moon H."/>
<person name="Lantz M."/>
<person name="Rebecchi K."/>
<person name="Desaire H."/>
<person name="Mure M."/>
</authorList>
<dbReference type="PubMed" id="23319596"/>
<dbReference type="DOI" id="10.1074/jbc.C112.421768"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>GLYCOSYLATION AT ASN-455 AND ASN-644</scope>
<scope>MUTAGENESIS OF ASN-455 AND ASN-644</scope>
<scope>CROSS-LINK FORMATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="6 7 11 12 13 15">Mediates the post-translational oxidative deamination of lysine residues on target proteins leading to the formation of deaminated lysine (allysine). When secreted in extracellular matrix, promotes cross-linking of extracellular matrix proteins by mediating oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin. Acts as a regulator of sprouting angiogenesis, probably via collagen IV scaffolding. When nuclear, acts as a transcription corepressor and specifically mediates deamination of trimethylated 'Lys-4' of histone H3 (H3K4me3), a specific tag for epigenetic transcriptional activation. Involved in epithelial to mesenchymal transition (EMT) via interaction with SNAI1 and participates in repression of E-cadherin, probably by mediating deamination of histone H3. Also involved in E-cadherin repression following hypoxia, a hallmark of epithelial to mesenchymal transition believed to amplify tumor aggressiveness, suggesting that it may play a role in tumor progression. Acts as a regulator of chondrocyte differentiation, probably by regulating expression of factors that control chondrocyte differentiation.</text>
</comment>
<comment type="catalytic activity">
<text evidence="8 9 16">[Protein]-L-lysine + O(2) + H(2)O = [protein]-(S)-2-amino-6-oxohexanoate + NH(3) + H(2)O(2).</text>
</comment>
<comment type="cofactor">
<cofactor evidence="1">
<name>Cu cation</name>
<dbReference type="ChEBI" id="CHEBI:23378"/>
</cofactor>
</comment>
<comment type="cofactor">
<cofactor evidence="2">
<name>lysine tyrosylquinone residue</name>
<dbReference type="ChEBI" id="CHEBI:20489"/>
</cofactor>
<text evidence="2">Contains 1 lysine tyrosylquinone.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="8 9 10 16">According to some reports, it is inhibited by beta-aminopropionitrile (BAPN) (PubMed:20439985 and PubMed:23319596). According to another report, it is not inhibited by beta-aminopropionitrile (BAPN) (PubMed:20306300). Specifically inhibited by a mouse monoclonal antibody AB0023, inhibition occurs in a non-competitive manner.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="9 16">1.01 mM for 1,5-diaminopentane</KM>
<KM evidence="9 16">1.05 mM for spermine</KM>
<KM evidence="9 16">0.59 uM for tropoelastin (without the first three SRCR domains)</KM>
<KM evidence="9 16">0.62 uM for tropoelastin (without all four SRCR domains)</KM>
<text>kcat is 2.04 min(-1) with tropoelastin as substrate (without the first three SRCR domains). kcat is 0.62 min(-1) with tropoelastin as substrate (without all four SRCR domains).</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="6">Component of some chromatin repressor complex. Interacts with SNAI1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7172227"/>
<interactant intactId="EBI-530054">
<id>Q15910</id>
<label>EZH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7172227"/>
<interactant intactId="EBI-301834">
<id>Q13547</id>
<label>HDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7172227"/>
<interactant intactId="EBI-4289961">
<id>P49006</id>
<label>MARCKSL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7172227"/>
<interactant intactId="EBI-347218">
<id>Q96ST3</id>
<label>SIN3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16">Secreted</location>
<location evidence="16">extracellular space</location>
<location evidence="16">extracellular matrix</location>
<location evidence="16">basement membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Chromosome</location>
</subcellularLocation>
<text evidence="15">Associated with chromatin (PubMed:22483618). It is unclear how LOXL2 is nuclear: it contains a clear signal sequence and is predicted to localize in the extracellular medium (PubMed:22483618). However, different reports confirmed the intracellular location and its key role in transcription regulation (PubMed:22483618).</text>
</comment>
<comment type="tissue specificity">
<text>Expressed in many tissues. Highest expression in reproductive tissues, placenta, uterus and prostate. Up-regulated in a number of cancers cells and tissues.</text>
</comment>
<comment type="induction">
<text evidence="7">Strongly induced in hypoxia. Direct transcriptional target of HIF1A.</text>
</comment>
<comment type="domain">
<text>The fourth SRCR domain plays a important role in optimizing the catalytic activity of the lysyl-oxidase like (LOX) catalytic domain.</text>
</comment>
<comment type="PTM">
<text evidence="16">The lysine tyrosylquinone cross-link (LTQ) is generated by condensation of the epsilon-amino group of a lysine with a topaquinone produced by oxidation of tyrosine.</text>
</comment>
<comment type="PTM">
<text evidence="16">N-glycosylated. N-glycosylation on Asn-455 and Asn-644 may be essential for proper folding and secretion; may be composed of a fucosylated carbohydrates attached to a trimannose N-linked glycan core.</text>
</comment>
<comment type="miscellaneous">
<text evidence="19 20">Its overexpression in a number of cancer and its ability to promote epithelial to mesenchymal transition suggest that LOXL2 might play a role in tumor progression: expression is correlated with metastasis and decreased survival in patients with aggressive breast cancer (PubMed:21732535). Allosteric inhibition by AB0023 inhibits formation of the tumor microenvironment and reduces metastatic tumor burden in xenograft models (PubMed:20818376 and PubMed:21732535). However, inhibiting the enzyme activity of LOXL2 may not be sufficient, since mutants that lack enzyme activity or inhibition of the activity by AB0023 antibody does not prevent inhibition of the differentiation of keratinocytes, thereby promoting development of squamous cell carcinomas (PubMed:22157764).</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the lysyl oxidase family.</text>
</comment>
<comment type="sequence caution" evidence="18">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="AAD34343" version="1"/>
</conflict>
<location>
<position position="775"/>
</location>
<text>Translated as stop.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/LOXL2ID41192ch8p21.html"/>
</comment>
<dbReference type="EC" id="1.4.3.13" evidence="8 9 16"/>
<dbReference type="EMBL" id="U89942">
<property type="protein sequence ID" value="AAB49697.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312266">
<property type="protein sequence ID" value="BAG35197.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222477">
<property type="protein sequence ID" value="BAD96197.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC090197">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000594">
<property type="protein sequence ID" value="AAH00594.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF117949">
<property type="protein sequence ID" value="AAD34343.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34864.1"/>
<dbReference type="RefSeq" id="NP_002309.1">
<property type="nucleotide sequence ID" value="NM_002318.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.626637"/>
<dbReference type="ProteinModelPortal" id="Q9Y4K0"/>
<dbReference type="SMR" id="Q9Y4K0"/>
<dbReference type="BioGrid" id="110201">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="IntAct" id="Q9Y4K0">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="MINT" id="MINT-4053647"/>
<dbReference type="STRING" id="9606.ENSP00000373783"/>
<dbReference type="ChEMBL" id="CHEMBL3714029"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2853"/>
<dbReference type="iPTMnet" id="Q9Y4K0"/>
<dbReference type="PhosphoSitePlus" id="Q9Y4K0"/>
<dbReference type="BioMuta" id="LOXL2"/>
<dbReference type="DMDM" id="13878585"/>
<dbReference type="EPD" id="Q9Y4K0"/>
<dbReference type="MaxQB" id="Q9Y4K0"/>
<dbReference type="PaxDb" id="Q9Y4K0"/>
<dbReference type="PeptideAtlas" id="Q9Y4K0"/>
<dbReference type="PRIDE" id="Q9Y4K0"/>
<dbReference type="DNASU" id="4017"/>
<dbReference type="Ensembl" id="ENST00000389131">
<property type="protein sequence ID" value="ENSP00000373783"/>
<property type="gene ID" value="ENSG00000134013"/>
</dbReference>
<dbReference type="GeneID" id="4017"/>
<dbReference type="KEGG" id="hsa:4017"/>
<dbReference type="UCSC" id="uc003xdh.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4017"/>
<dbReference type="DisGeNET" id="4017"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000134013.15"/>
<dbReference type="GeneCards" id="LOXL2"/>
<dbReference type="H-InvDB" id="HIX0007387"/>
<dbReference type="HGNC" id="HGNC:6666">
<property type="gene designation" value="LOXL2"/>
</dbReference>
<dbReference type="HPA" id="CAB025848"/>
<dbReference type="HPA" id="HPA036257"/>
<dbReference type="HPA" id="HPA056542"/>
<dbReference type="MIM" id="606663">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y4K0"/>
<dbReference type="OpenTargets" id="ENSG00000134013"/>
<dbReference type="PharmGKB" id="PA30429"/>
<dbReference type="eggNOG" id="ENOG410IE2X">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XSN1">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140830"/>
<dbReference type="HOGENOM" id="HOG000220841"/>
<dbReference type="HOVERGEN" id="HBG052336"/>
<dbReference type="InParanoid" id="Q9Y4K0"/>
<dbReference type="KO" id="K00280"/>
<dbReference type="OMA" id="FSMDCTG"/>
<dbReference type="OrthoDB" id="EOG091G02XD"/>
<dbReference type="PhylomeDB" id="Q9Y4K0"/>
<dbReference type="TreeFam" id="TF326061"/>
<dbReference type="BRENDA" id="1.4.3.13">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1566948">
<property type="pathway name" value="Elastic fibre formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2243919">
<property type="pathway name" value="Crosslinking of collagen fibrils"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9Y4K0"/>
<dbReference type="ChiTaRS" id="LOXL2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="LOXL2"/>
<dbReference type="GenomeRNAi" id="4017"/>
<dbReference type="PRO" id="PR:Q9Y4K0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000134013"/>
<dbReference type="CleanEx" id="HS_LOXL2"/>
<dbReference type="ExpressionAtlas" id="Q9Y4K0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y4K0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005604">
<property type="term" value="C:basement membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0031012">
<property type="term" value="C:extracellular matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005507">
<property type="term" value="F:copper ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0009055">
<property type="term" value="F:electron transfer activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070492">
<property type="term" value="F:oligosaccharide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004720">
<property type="term" value="F:protein-lysine 6-oxidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005044">
<property type="term" value="F:scavenger receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006464">
<property type="term" value="P:cellular protein modification process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030199">
<property type="term" value="P:collagen fibril organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016569">
<property type="term" value="P:covalent chromatin modification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043542">
<property type="term" value="P:endothelial cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001935">
<property type="term" value="P:endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032332">
<property type="term" value="P:positive regulation of chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046688">
<property type="term" value="P:response to copper ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002040">
<property type="term" value="P:sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="3.10.250.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001695">
<property type="entry name" value="Lysyl_oxidase"/>
</dbReference>
<dbReference type="InterPro" id="IPR019828">
<property type="entry name" value="Lysyl_oxidase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001190">
<property type="entry name" value="SRCR"/>
</dbReference>
<dbReference type="InterPro" id="IPR017448">
<property type="entry name" value="SRCR-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036772">
<property type="entry name" value="SRCR-like_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF01186">
<property type="entry name" value="Lysyl_oxidase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00530">
<property type="entry name" value="SRCR"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PRINTS" id="PR00074">
<property type="entry name" value="LYSYLOXIDASE"/>
</dbReference>
<dbReference type="PRINTS" id="PR00258">
<property type="entry name" value="SPERACTRCPTR"/>
</dbReference>
<dbReference type="SMART" id="SM00202">
<property type="entry name" value="SR"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56487">
<property type="entry name" value="SSF56487"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS00926">
<property type="entry name" value="LYSYL_OXIDASE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00420">
<property type="entry name" value="SRCR_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50287">
<property type="entry name" value="SRCR_2"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0084">Basement membrane</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0186">Copper</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0272">Extracellular matrix</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0886">LTQ</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0801">TPQ</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="Lysyl oxidase homolog 2" id="PRO_0000018532">
<location>
<begin position="26"/>
<end position="774"/>
</location>
</feature>
<feature type="domain" description="SRCR 1" evidence="4">
<location>
<begin position="58"/>
<end position="159"/>
</location>
</feature>
<feature type="domain" description="SRCR 2" evidence="4">
<location>
<begin position="188"/>
<end position="302"/>
</location>
</feature>
<feature type="domain" description="SRCR 3" evidence="4">
<location>
<begin position="326"/>
<end position="425"/>
</location>
</feature>
<feature type="domain" description="SRCR 4" evidence="4">
<location>
<begin position="435"/>
<end position="544"/>
</location>
</feature>
<feature type="region of interest" description="Lysyl-oxidase like">
<location>
<begin position="548"/>
<end position="751"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper" evidence="3">
<location>
<position position="626"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper" evidence="3">
<location>
<position position="628"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper" evidence="3">
<location>
<position position="630"/>
</location>
</feature>
<feature type="modified residue" description="2',4',5'-topaquinone" evidence="2">
<location>
<position position="689"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="288"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="16">
<location>
<position position="455"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="16">
<location>
<position position="644"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="84"/>
<end position="148"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="97"/>
<end position="158"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="128"/>
<end position="138"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="218"/>
<end position="291"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="231"/>
<end position="301"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="265"/>
<end position="275"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="351"/>
<end position="414"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="364"/>
<end position="424"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="395"/>
<end position="405"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="464"/>
<end position="530"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="477"/>
<end position="543"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="511"/>
<end position="521"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="573"/>
<end position="579"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="625"/>
<end position="673"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="657"/>
<end position="663"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="685"/>
<end position="695"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="732"/>
<end position="746"/>
</location>
</feature>
<feature type="cross-link" description="Lysine tyrosylquinone (Lys-Tyr)" evidence="16">
<location>
<begin position="653"/>
<end position="689"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4602894." id="VAR_050010">
<original>S</original>
<variation>W</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1063582." id="VAR_024527" evidence="5 17">
<original>M</original>
<variation>L</variation>
<location>
<position position="570"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits secretion." evidence="16">
<original>N</original>
<variation>Q</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of catalytic activity and abolishes ability to repress transcription." evidence="15">
<original>HRH</original>
<variation>ARA</variation>
<location>
<begin position="626"/>
<end position="628"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits secretion." evidence="16">
<original>N</original>
<variation>Q</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect ability to inhibit keratinocyte differentiation." evidence="14">
<original>Y</original>
<variation>F</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG35197." ref="2" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAD96197." ref="3" evidence="18">
<original>E</original>
<variation>G</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAD34343." ref="6" evidence="18">
<original>L</original>
<variation>Q</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG35197." ref="2" evidence="18">
<original>Q</original>
<variation>R</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAD34343." ref="6" evidence="18">
<original>H</original>
<variation>Q</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAD34343." ref="6" evidence="18">
<original>C</original>
<variation>S</variation>
<location>
<position position="746"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P16636"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P33072"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00196"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16096638"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20026874"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20306300"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20439985"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20818376"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21233336"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21732535"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21835952"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22157764"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22483618"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23319596"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<evidence key="19" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21732535"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22157764"/>
</source>
</evidence>
<sequence length="774" mass="86725" checksum="9DF5D25D4824BCCD" modified="1999-11-01" version="1" precursor="true">
MERPLCSHLCSCLAMLALLSPLSLAQYDSWPHYPEYFQQPAPEYHQPQAPANVAKIQLRL
AGQKRKHSEGRVEVYYDGQWGTVCDDDFSIHAAHVVCRELGYVEAKSWTASSSYGKGEGP
IWLDNLHCTGNEATLAACTSNGWGVTDCKHTEDVGVVCSDKRIPGFKFDNSLINQIENLN
IQVEDIRIRAILSTYRKRTPVMEGYVEVKEGKTWKQICDKHWTAKNSRVVCGMFGFPGER
TYNTKVYKMFASRRKQRYWPFSMDCTGTEAHISSCKLGPQVSLDPMKNVTCENGLPAVVS
CVPGQVFSPDGPSRFRKAYKPEQPLVRLRGGAYIGEGRVEVLKNGEWGTVCDDKWDLVSA
SVVCRELGFGSAKEAVTGSRLGQGIGPIHLNEIQCTGNEKSIIDCKFNAESQGCNHEEDA
GVRCNTPAMGLQKKLRLNGGRNPYEGRVEVLVERNGSLVWGMVCGQNWGIVEAMVVCRQL
GLGFASNAFQETWYWHGDVNSNKVVMSGVKCSGTELSLAHCRHDGEDVACPQGGVQYGAG
VACSETAPDLVLNAEMVQQTTYLEDRPMFMLQCAMEENCLSASAAQTDPTTGYRRLLRFS
SQIHNNGQSDFRPKNGRHAWIWHDCHRHYHSMEVFTHYDLLNLNGTKVAEGHKASFCLED
TECEGDIQKNYECANFGDQGITMGCWDMYRHDIDCQWVDITDVPPGDYLFQVVINPNFEV
AESDYSNNIMKCRSRYDGHRIWMYNCHIGGSFSEETEKKFEHFSGLLNNQLSPQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>